Similarly, 4T1‐hTROP2 cells with USP10 knockdown and subsequent reintroduction of B7‐H4 also showed notable increases in tumor growth and enhanced resistance to SG (Figure S8J–M, Supporting Information), confirming the axis's critical role in TNBC progression and response to SG therapy. This evidence concerns the gene USP10 and neoplasm.